LDL-Cholesterol Lowering Effect of KB2115 as Add on to Ezetimibe

Clinical trial NCT00677248 · COMPLETED

Trial details

NCT number: NCT00677248
Sponsor: Karo Bio AB
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hypercholesterolemia

Start date: 2008-04-01
Primary completion: 2008-09-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.